Cao Peixuan, Zhu Xiangyu, Yang Ying, Zhu Yujie, Li Jie
Department of Obstetrics and Gynecology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, Jiangsu 210008, China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018 Jun 10;35(3):397-399. doi: 10.3760/cma.j.issn.1003-9406.2018.03.020.
To apply high-throughput sequencing for the detection of potential mutation in a methylmalonic academia pedigree for which no proband was available.
For a couple who had previously given birth to an affected child, 14 genes were re-sequenced by high-throughput sequencing. Suspected mutations were validated by Sanger sequencing. Specific mutations were tested for amniotic fluid sample from the fetus.
High-throughput sequencing suggested that the husband has carried a heterozygous mutation of the MUT gene (Exon 3: c.729_730insTT; p.Asp244Leufs*39), while the wife also carried a heterozygous mutation of the MUT gene (Exon 5: c.914T>C; p.Leu305Ser). Both mutations were confirmed by Sanger sequencing. Testing of amniotic sample suggested that the fetus has carried neither mutation. Follow-up has found no sign of methylmalonic academia in the neonate.
High-throughput sequencing is a sensitive method to screen a bunch of genes in a single test. For autosomal recessive diseases, when no proband is available, carrier testing for both parents with high-throughput sequencing can provide an alternative approach, though great caution should be taken in the setting of prenatal diagnosis.
应用高通量测序技术检测一个无先证者的甲基丙二酸血症家系中的潜在突变。
对于一对曾生育过患病子女的夫妇,通过高通量测序对14个基因进行重测序。可疑突变通过桑格测序进行验证。对胎儿的羊水样本检测特定突变。
高通量测序提示丈夫携带MUT基因的杂合突变(外显子3:c.729_730insTT;p.Asp244Leufs*39),而妻子也携带MUT基因的杂合突变(外显子5:c.914T>C;p.Leu305Ser)。两种突变均经桑格测序证实。羊水样本检测提示胎儿未携带任何一种突变。随访发现新生儿无甲基丙二酸血症迹象。
高通量测序是一种在单次检测中筛查多个基因的灵敏方法。对于常染色体隐性疾病,当无先证者时,对双亲进行高通量测序的携带者检测可提供一种替代方法,不过在进行产前诊断时应极其谨慎。